Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Medication overuse headache].

A Fumal1, D Magis, J Schoenen

  • 1Services de Neurologie et de Neuroanatomie, Unité de Recherches sur les Céphalées, Université de Liège.

Revue Medicale De Liege
|June 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Integrating new migraine treatments into clinical practice (part 1) : management of acute migraine attack].

Revue medicale de Liege·2023
Same author

Monoclonal antibodies blocking CGRP transmission: An update on their added value in migraine prevention.

Revue neurologique·2020
Same author

[Clinical pathway evaluation for left colectomy in abdominal surgery].

Revue medicale de Liege·2017
Same author

About a case of Wernicke's encephalopathy after sleeve gastrectomy.

Eating and weight disorders : EWD·2016
Same author

One-year prevalence of migraine using a validated extended French version of the ID Migraine™: A Belgian population-based study.

Revue neurologique·2015
Same author

Analysis and clinical correlates of 20 Hz photic driving on routine EEG in migraine.

Acta neurologica Belgica·2014
Same journal

[Nature prescriptions and health promotion : sharing experience from primary care].

Revue medicale de Liege·2026
Same journal

[Eco-health: shared perspectives on primary care practice].

Revue medicale de Liege·2026
Same journal

[The strategic role of primary care in emerging diseases : surveillance, research, and preparedness].

Revue medicale de Liege·2026
Same journal

[Environmental impact of medicines and approaches for more eco responsible use].

Revue medicale de Liege·2026
Same journal

[Climate change and skin].

Revue medicale de Liege·2026
Same journal

[From Silent Spring to neuronal silence : pesticides and neurodegenerative diseases].

Revue medicale de Liege·2026
See all related articles

Medication overuse headache (MOH) may stem from medial orbitofrontal cortex hypometabolism, similar to substance dependence. This brain region

Area of Science:

  • Neuroscience
  • Neurology
  • Addiction Medicine

Context:

  • Medication overuse headache (MOH) is a common complication of episodic migraine and tension-type headaches.
  • It arises from the overuse of acute headache medications like analgesics, ergotamine, or triptans.
  • MOH affects 1-2% of the general population and up to 20% of patients in specialized headache clinics.

Purpose:

  • To investigate the neurobiological mechanisms underlying medication overuse headache (MOH).
  • To explore the role of the medial orbitofrontal cortex in MOH pathogenesis and relapse.
  • To identify potential biomarkers for MOH susceptibility and treatment response.

Summary:

  • A study using FDG-PET in 16 migraineurs with MOH revealed persistent medial orbitofrontal cortex hypometabolism.

Related Experiment Videos

  • This hypometabolism was observed both before and after medication withdrawal, and is comparable to findings in substance abuse.
  • The orbitofrontal cortex's role in drive, decision-making, and drug dependence suggests its hypoactivity may predispose individuals to MOH and relapse.

    • Impact:

    • Findings suggest that medial orbitofrontal cortex hypoactivity may be a predisposing factor for developing MOH.
    • Understanding these mechanisms could lead to targeted preventive strategies for individuals at risk of MOH.
    • Medication withdrawal is crucial for improving headache outcomes and enhancing the effectiveness of preventive therapies.